Related Experiment Video

Updated: Aug 19, 2026

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells
08:28

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Published on: May 9, 2025

Her-2/neu as a paradigm of a tumor-specific target for therapy

A Choudhury1, R Kiessling

  • 1Department of Oncology-Pathology, Cancer Centrum Karolinska, Karolinska Institutet R8:01, 17176 Stockholm, Sweden.

Breast Disease
|February 3, 2005
PubMed

Insights

Human Epidermal growth factor Receptor 2 (HER2) protooncogene amplification in carcinomas correlates with poor prognosis. Understanding HER2's role in cancer and immune evasion is key for developing new targeted therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • The Human Epidermal growth factor Receptor 2 (HER2) protooncogene is amplified in various carcinomas.
  • HER2 overexpression is linked to unfavorable prognosis and resistance to conventional treatments.
  • Current therapeutic strategies for HER2-overexpressing tumors are limited.

Purpose of the Study:

  • To elucidate the biochemical and physiological functions of HER2 in oncogenesis.
  • To investigate the role of HER2 in tumor immune escape.
  • To identify new therapeutic targets for HER2-driven cancers.

Main Methods:

  • Literature review on HER2 function and therapeutic approaches.
  • Analysis of oncogenic pathways involving HER2.
  • Exploration of HER2's impact on the tumor microenvironment and immune surveillance.

Main Results:

  • HER2 amplification drives tumor growth and progression.
  • HER2 overexpression contributes to immune evasion by tumor cells.
  • Targeting HER2 presents a promising therapeutic avenue.

Conclusions:

  • A comprehensive understanding of HER2's multifaceted roles is crucial.
  • Developing novel HER2-targeting therapies can overcome treatment resistance.
  • Targeting HER2 may enhance anti-tumor immunity for improved patient outcomes.

More Related Videos

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.